{
  "claim_id": "claim_000",
  "claim": "Flublok is approved for adults 18 years and older",
  "document": "FlublokPI",
  "additional_evidence_check": {
    "checked_for_more": true,
    "found_additional": true,
    "additional_count": 2
  },
  "completeness_stats": {
    "existing_evidence": 0,
    "new_evidence_found": 2,
    "total_evidence": 2
  },
  "verified_evidence": [],
  "new_evidence": [
    {
      "id": "comp_1",
      "quote": "Safety and effectiveness of Flublok have not been established in children 3 years to less than 18 years of age.",
      "relevance_explanation": "This quote supports the claim by indicating that Flublok is not approved for use in individuals under 18 years old, thereby implying its approval is for adults 18 years and older.",
      "source": "completeness_check",
      "metadata": {
        "extraction_round": 2,
        "targeted_aspect": "general"
      }
    },
    {
      "id": "comp_2",
      "quote": "Data from a randomized, controlled trial demonstrated that children 6 months to less than 3 years of age had diminished hemagglutinin inhibition (HI) responses to Flublok compared to au. S.-licensed influenza vaccine approved for use in this population, strongly suggesting that Flublok would not be effective in children younger than 3 years of age (6).",
      "relevance_explanation": "This quote provides evidence that Flublok is not intended for children under 3 years, supporting the claim that its approved use is for adults 18 years and older.",
      "source": "completeness_check",
      "metadata": {
        "extraction_round": 2,
        "targeted_aspect": "general"
      }
    }
  ],
  "model_used": "gpt-4.1"
}